BioLife4D
About this raise
BioLife4D is raising funds on Dalmore Group through Reg A+ crowdfunding. The company aims to use the current advances in cardiac tissue engineering to build human hearts suitable for implantation. The company will use 3D bioprinting to make patient-specific hearts using the patients’ own cells. The hearts of BioLife4D will have a precise fit and a perfect genetic match. BioLife4D has printed a mini-heart and working on a functional mini-heart for toxicity testing. Steven Morris founded BioLife4D in 2016. The current crowdfunding campaign has no minimum target and a maximum target of $46,133,806. The campaign proceeds will be used for marketing, salaries, rent, equipment, licenses, and working capital.
Investment Overview
Invested : $275,333
Deal Terms
Total Commitments
- Platform
- Dalmore Group
- Start Date
- 10/23/2020
- Close Date
- 10/23/2021
$1,080
$46,133,806
$1,080
Equity - Common
RegA+
$13.50
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Capital Intensity
- Location
- Buffalo Grove, Illinois
- Company Website
-
Visit Website
Team
- Employees
- 1
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 10/23/2021 | Dalmore Group | - | $275,333 | Equity - Common | Funded | RegA+ |